Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy.
Low-dose alendronate is as effective as standard-dose alendronate, and its effects continue after drug withdrawal in postmenopausal osteoporotic women who are being treated with estrogen.